She began to stabilize at the outside hospital until one week after admission when she developed increasing abdominal pain and found to have an increasing white blood cell count to 15,000 and an increased pancreatic enzyme level.
She obtained an abdominal CT which showed possible pancreatic pseudocyst, and she was then transferred to [**Hospital1 1444**] for consultation and evaluation by Dr. [**Last Name (STitle) 1305**] in the Gold Surgery Service.
PHYSICAL EXAMINATION ON PRESENTATION:  Examination on admission revealed temperature was 100.2, heart rate was 80, blood pressure was 138/70, respiratory rate was 20, 98% on room air.
The chest was clear to auscultation bilaterally.
PERTINENT LABORATORY DATA ON PRESENTATION:  Her laboratories on admission included a white blood cell count of 13.1, hematocrit of 29.7, and platelets of 612.
PT of 14.7, PTT of 30.7, INR of 1.9.
Sodium of 137, potassium of 4.1, chloride of 103, bicarbonate of 22, blood urea nitrogen of 12, creatinine of 0.6, blood glucose of 164.
ALT was 17, AST was 24, alkaline phosphatase was 121, total bilirubin was 0.3, amylase was 252, lipase was 594.
Calcium was 9, magnesium was 1.7, phosphorous was 4.3.
Laboratories were sent, and she was found to have an amylase of 277, and a lipase of 816, and her fingerstick blood sugar levels were difficult to control with an insulin sliding-scale and ranged anywhere from 250 to 350.
She was continued on total parenteral nutrition, and she was transferred to the Surgical Intensive Care Unit for close monitoring for her pancreatitis.
The fluid was sent for culture which was negative.
She was started on imipenem antibiotics and continued to have increasing white blood cell count and temperature and abdominal pain.
Cultures were sent, and the patient was found to have a urinary tract infection that grew enterococcus sensitive to vancomycin.
The patient's temperatures began to subside, and the patient's white blood cell count normalized to 9.
The patient's pain continued to improve, and physical examination showed markedly decreased tenderness in the epigastric region.
[**MD Number(1) 1307**]  Dictated By:[**Last Name (NamePattern1) 3835**]  MEDQUIST36  D:  [**2195-6-24**]  22:02 T:  [**2195-6-25**]  12:50 JOB#:  [**Job Number 42540**]
